Epstein-Barr virus vaccine - iosBio
Alternative Names: OraPro™-EBVLatest Information Update: 25 Jul 2025
At a glance
- Originator iosBio
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Epstein-Barr virus infections
Most Recent Events
- 25 Jul 2025 Preclinical trials in Epstein-Barr virus infections (Prevention) in United Kingdom (PO)